(Q46788971)

25 December 2017

title

Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts (English)

1 reference

25 December 2017

author name string

Roselle Gélinas

1

1 reference

25 December 2017

François Labarthe

2

1 reference

25 December 2017

Bertrand Bouchard

3

1 reference

25 December 2017

Janie Mc Duff

4

1 reference

25 December 2017

Guy Charron

5

1 reference

25 December 2017

Martin E Young

6

1 reference

25 December 2017

Christine Des Rosiers

7

1 reference

25 December 2017

publication date

25 January 2008

1 reference

25 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

25 December 2017

volume

294

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

H1571-80

1 reference

25 December 2017

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Anaplerotic molecules: current and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Evidence of separate pathways for lactate uptake and release by the perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Mechanistic stoichiometry of mitochondrial oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Medium-chain fatty acids as metabolic therapy in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

The subcellular location of isozymes of NADP-isocitrate dehydrogenase in tissues from pig, ox and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Mouse models of mitochondrial dysfunction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Recognition and management of fatty acid oxidation defects: a series of 107 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Energy metabolism in the normal and failing heart: potential for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Myocardial substrate metabolism in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Role of NADP+ (corrected)-linked malic enzymes as regulators of the pool size of tricarboxylic acid-cycle intermediates in the perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Intrinsic diurnal variations in cardiac metabolism and contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

Role of oxidative stress in cardiac dysfunction of PPARα−/− mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01340.2007

10.1152/AJPHEART.01340.2007

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18223187

1 reference

25 December 2017